• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990年至2021年中国动脉粥样硬化性心血管疾病的流行病学及负担:全球疾病负担研究2021的结果

The epidemiology and burden of atherosclerotic cardiovascular disease in China from 1990 to 2021: findings from the global burden of disease 2021.

作者信息

Hou Xin-Zheng, Wu Qian, Yang Ying-Tian, Ye Xue-Jiao, Lv Qian-Yu, Yang Chen-Yan, Huang Ming-Yu, Wang Shi-Han

机构信息

Department of Cardiovascular Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

出版信息

Front Public Health. 2025 Jun 26;13:1529506. doi: 10.3389/fpubh.2025.1529506. eCollection 2025.

DOI:10.3389/fpubh.2025.1529506
PMID:40642239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12240750/
Abstract

BACKGROUND

Atherosclerotic cardiovascular disease (ASCVD) significantly threatens the health of the Chinese population. Understanding its epidemiological burden is vital for targeted interventions.

METHODS

Using Global Burden of Diseases (GBD) 2021 data, we assessed Disability-Adjusted Life Years (DALYs), incidence, prevalence, and mortality of ischemic heart disease (IHD), stroke, and lower extremity peripheral artery disease (PAD) in China in 2021. Joinpoint regression analyzed trends from 1990 to 2021, and risk factor contributions to the disease burden were evaluated.

FINDINGS

In 2021, age-standardized rates (ASRs) per 100,000 population for IHD (DALYs, incidence, prevalence, mortality) were 1856.5 (1548.7, 2159.8), 365.7 (293.3, 440.1), 3042.3 (2601.7, 3629.9), and 110.9 (92.4, 128.6), respectively, with males bearing a higher burden. For stroke, ASRs were 2648 (2253.4, 3076.9), 204.8 (181, 231.5), 1301.4 (1200.6, 1405.7), and 138 (116.7, 160.3), also higher in males. Lower extremity PAD showed ASRs of 8.4 (4.9, 14.3), 112.7 (97.8, 130.7), 1331.1 (1147.5, 1544.2), and 0.1 (0.1, 0.2), with a higher burden in females. Metabolic risks had the largest population-attributable fraction.

CONCLUSION

As of 2021, the epidemiological burden of IHD, stroke, and PAD in China remains substantial, with notable gender disparities. Metabolic risks significantly contribute to this burden.

摘要

背景

动脉粥样硬化性心血管疾病(ASCVD)严重威胁中国人群的健康。了解其流行病学负担对于有针对性的干预措施至关重要。

方法

利用全球疾病负担(GBD)2021年的数据,我们评估了2021年中国缺血性心脏病(IHD)、中风和下肢外周动脉疾病(PAD)的伤残调整生命年(DALYs)、发病率、患病率和死亡率。Joinpoint回归分析了1990年至2021年的趋势,并评估了风险因素对疾病负担的贡献。

研究结果

2021年,每10万人口中IHD(DALYs、发病率、患病率、死亡率)的年龄标准化率(ASRs)分别为1856.5(1548.7,2159.8)、365.7(293.3,440.1)、3042.3(2601.7,3629.9)和110.9(92.4,128.6),男性负担较重。中风的ASRs分别为2648(2253.4,3076.9)、204.8(181,231.5)、1301.4(1200.6,1405.7)和138(116.7,160.3),男性也更高。下肢PAD的ASRs为8.4(4.9,14.3)、112.7(97.8,130.7)、1331.1(1147.5,1544.2)和0.1(0.1,0.2),女性负担较重。代谢风险在人群归因分数中占比最大。

结论

截至2021年,中国IHD、中风和PAD的流行病学负担仍然很大,存在明显的性别差异。代谢风险对这一负担有显著贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/183e/12240750/39f319c69a9f/fpubh-13-1529506-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/183e/12240750/7e1127813341/fpubh-13-1529506-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/183e/12240750/605f5c280866/fpubh-13-1529506-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/183e/12240750/39f319c69a9f/fpubh-13-1529506-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/183e/12240750/7e1127813341/fpubh-13-1529506-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/183e/12240750/605f5c280866/fpubh-13-1529506-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/183e/12240750/39f319c69a9f/fpubh-13-1529506-g003.jpg

相似文献

1
The epidemiology and burden of atherosclerotic cardiovascular disease in China from 1990 to 2021: findings from the global burden of disease 2021.1990年至2021年中国动脉粥样硬化性心血管疾病的流行病学及负担:全球疾病负担研究2021的结果
Front Public Health. 2025 Jun 26;13:1529506. doi: 10.3389/fpubh.2025.1529506. eCollection 2025.
2
Burden of knee osteoarthritis in China and globally: 1990-2045.中国及全球膝关节骨关节炎负担:1990 - 2045年
BMC Musculoskelet Disord. 2025 Jul 1;26(1):582. doi: 10.1186/s12891-025-08858-8.
3
Global pattern, trend and cross-country inequalities of inguinal, femoral, and abdominal hernia among individuals aged 60 and above from 1990 to 2021 and projections until 2040: a population-based study.1990年至2021年60岁及以上人群腹股沟疝、股疝和腹疝的全球模式、趋势及国家间不平等状况以及至2040年的预测:一项基于人群的研究
Surg Endosc. 2025 May 28. doi: 10.1007/s00464-025-11810-5.
4
Global, regional, and national burden of IHD attributable to PM pollution aged 70 and above: an age-period-cohort modeling and frontiers analysis study.70岁及以上人群中因细颗粒物污染导致的缺血性心脏病的全球、区域和国家负担:一项年龄-时期-队列建模与前沿分析研究
Front Public Health. 2025 Jun 4;13:1573599. doi: 10.3389/fpubh.2025.1573599. eCollection 2025.
5
Systematic analysis of gout burden among young adults in China from 1990 to 2021: findings from the global burden of disease study 2021.1990年至2021年中国青年成年人痛风负担的系统分析:全球疾病负担研究2021的结果
Front Public Health. 2025 Jun 9;13:1613801. doi: 10.3389/fpubh.2025.1613801. eCollection 2025.
6
A trend analysis of the burden of lower extremity peripheral arterial disease in China, 1990 to 2021: based on the Global Burden of Disease Study 2021.1990年至2021年中国下肢外周动脉疾病负担的趋势分析:基于《2021年全球疾病负担研究》
Front Public Health. 2025 Jun 19;13:1506748. doi: 10.3389/fpubh.2025.1506748. eCollection 2025.
7
Incidence and disability-adjusted life-years of infective endocarditis in China from 1990 to 2021: comparison with G20 based on the Global Burden of Disease Study 2021.1990年至2021年中国感染性心内膜炎的发病率和伤残调整生命年:基于《2021年全球疾病负担研究》与二十国集团的比较
BMJ Open. 2025 Jul 6;15(7):e094490. doi: 10.1136/bmjopen-2024-094490.
8
[Disease burden of spinal fractures in China from 1990 to 2021 and temporal trends: A comparative analysis based on the Global Burden of Disease Study 2021].1990年至2021年中国脊柱骨折的疾病负担及时间趋势:基于《2021年全球疾病负担研究》的比较分析
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025 Jun 15;39(6):762-768. doi: 10.7507/1002-1892.202504088.
9
Global burden and risk factors of peptic ulcer disease between 1990 and 2021: An analysis from the global burden of disease study 2021.1990年至2021年期间消化性溃疡疾病的全球负担及风险因素:来自《2021年全球疾病负担研究》的分析
PLoS One. 2025 Jul 11;20(7):e0325821. doi: 10.1371/journal.pone.0325821. eCollection 2025.
10
The disease burden, risk factors and future predictions of Alzheimer's disease and other types of dementia in Asia from 1990 to 2021.1990年至2021年亚洲阿尔茨海默病及其他类型痴呆症的疾病负担、风险因素及未来预测
J Prev Alzheimers Dis. 2025 May;12(5):100122. doi: 10.1016/j.tjpad.2025.100122. Epub 2025 Mar 7.

本文引用的文献

1
Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical Trial.匹伐他汀、前胶原途径与HIV患者的斑块稳定:REPRIEVE随机临床试验的二次分析
JAMA Cardiol. 2025 Mar 1;10(3):254-264. doi: 10.1001/jamacardio.2024.4115.
2
Disparities in high fasting plasma glucose-related cardiovascular disease burden in China.中国高空腹血糖相关心血管疾病负担的差异。
Nat Commun. 2024 Oct 11;15(1):8817. doi: 10.1038/s41467-024-53236-y.
3
Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021.
1990 年至 2021 年全球良性前列腺增生症、尿路感染、尿路结石、膀胱癌、肾癌和前列腺癌的负担。
Mil Med Res. 2024 Sep 18;11(1):64. doi: 10.1186/s40779-024-00569-w.
4
Global, regional, and national burden of tracheal, bronchus, and lung cancer and its risk factors from 1990 to 2021: findings from the global burden of disease study 2021.1990年至2021年气管、支气管和肺癌及其风险因素的全球、区域和国家负担:全球疾病负担研究2021的结果
EClinicalMedicine. 2024 Sep 5;75:102804. doi: 10.1016/j.eclinm.2024.102804. eCollection 2024 Sep.
5
Burden of cardiovascular disease among the Western Pacific region and its association with human resources for health, 1990-2021: a systematic analysis of the Global Burden of Disease Study 2021.1990 - 2021年西太平洋地区心血管疾病负担及其与卫生人力资源的关联:全球疾病负担研究2021的系统分析
Lancet Reg Health West Pac. 2024 Sep 3;51:101195. doi: 10.1016/j.lanwpc.2024.101195. eCollection 2024 Oct.
6
Lipoprotein(a) and cardiovascular disease.脂蛋白(a)与心血管疾病。
Lancet. 2024 Sep 28;404(10459):1255-1264. doi: 10.1016/S0140-6736(24)01308-4. Epub 2024 Sep 12.
7
Burden of non-communicable diseases in China and its provinces, 1990-2021: Results from the Global Burden of Disease Study 2021.中国及其省份的非传染性疾病负担,1990-2021 年:2021 年全球疾病负担研究结果。
Chin Med J (Engl). 2024 Oct 5;137(19):2325-2333. doi: 10.1097/CM9.0000000000003270. Epub 2024 Aug 28.
8
Global, regional, and national burden of ischemic stroke, 1990-2021: an analysis of data from the global burden of disease study 2021.1990 - 2021年全球、区域和国家缺血性卒中负担:基于2021年全球疾病负担研究数据的分析
EClinicalMedicine. 2024 Jul 27;75:102758. doi: 10.1016/j.eclinm.2024.102758. eCollection 2024 Sep.
9
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.204 个国家和地区 2022-2050 年疾病负担情景:2021 年全球疾病负担研究的预测分析。
Lancet. 2024 May 18;403(10440):2204-2256. doi: 10.1016/S0140-6736(24)00685-8.
10
Association of sleep characteristics with cardiovascular disease risk in adults over 40 years of age: a cross-sectional survey.40岁以上成年人睡眠特征与心血管疾病风险的关联:一项横断面调查。
Front Cardiovasc Med. 2024 Jan 24;11:1308592. doi: 10.3389/fcvm.2024.1308592. eCollection 2024.